DOI:
10.1055/s-00000097
Deutsche Zeitschrift für Onkologie
LinksClose Window
References
Gollob JA, Rathmell WK, Richmond TM, Marino CB, Miller EK, Grigson G, Watkins C, Gu L, Peterson BL, Wright JJ.
Phase II trial of sorafenib plus interferon alfa-2b as first-
or second-line therapy in patients with metastatic renal cell cancer.
J Clin Oncol 2007; 25: 3288-3295
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.